SARS-COV-2 vaccination after stem cell transplantation for scleroderma | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Letter

SARS-COV-2 vaccination after stem cell transplantation for scleroderma

Online download statistics by month:

Online download statistics by month: May 2021 to March 2024

	Abstract	Full	Pdf
May 2021	181	181	35
Jun 2021	395	388	96
Jul 2021	195	195	55
Aug 2021	103	100	57
Sep 2021	344	343	105
Oct 2021	188	188	116
Nov 2021	155	153	96
Dec 2021	102	98	53
Jan 2022	108	110	56
Feb 2022	64	76	42
Mar 2022	56	55	40
Apr 2022	93	88	40
May 2022	64	64	31
Jun 2022	66	62	41
Jul 2022	34	37	25
Aug 2022	48	47	20
Sep 2022	56	56	42
Oct 2022	49	48	22
Nov 2022	53	52	23
Dec 2022	20	20	11
Jan 2023	29	28	14
Feb 2023	53	52	8
Mar 2023	21	21	12
Apr 2023	28	1	0
May 2023	41	1	2
Jun 2023	45	2	5
Jul 2023	33	1	1
Aug 2023	37	1	1
Sep 2023	37	6	1
Oct 2023	28	2	0
Nov 2023	39	2	1
Dec 2023	41	3	4
Jan 2024	38	3	2
Feb 2024	21	2	2
Mar 2024	63	4	4
Total	2928	2490	1063